[{"edinetCode":"E03330","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":393.0,"averageTemporaryStaff":106.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1985000.0,"sharesOwendPercent":0.551,"outstandingShares":null,"numberOfSubsidiary":5.0,"bps":3332.72,"equityRatio":0.727,"cashAndCashEquivalents":7339146000.0,"assets":15148723000.0,"currentAssets":9844344000.0,"fixedAsset":5304379000.0,"tangibleFixedAssets":3740797000.0,"intangibleFixedAssets":17714000.0,"investmentAndOtherAssets":1545867000.0,"liabilities":3956149000.0,"currentLiabilities":3090325000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":865823000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":11192574000.0,"capitalStock":10820507000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":10382609000.0,"treasuryStock":-511990000.0,"valuationAndConversionAdjustments":187687000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":10133726000.0,"costOfSales":5078205000.0,"grossProfit":5055520000.0,"sgaExpenses":3835889000.0,"salaryAndBenefit":null,"depreciationAndSGA":154727000.0,"RDExpenses":null,"operatingIncome":1219631000.0,"nonOperatingIncome":57424000.0,"nonOperatingExpenses":7078000.0,"interestExpense":7078000.0,"ordinaryProfit":1269976000.0,"extraordinaryGain":141000.0,"extraordinaryLoss":125114000.0,"incomeBeforeTax":1145004000.0,"incomeTaxes":344300000.0,"netIncome":800703000.0,"netIncomeAttributableToOwnersOfTheParentCompany":797694000.0,"comprehensiveIncome":855812000.0,"eps":241.49,"dilutedEps":null,"dividendPerShare":null,"per":16.0,"roe":0.075,"cashFlowFromOperatingActivities":1195369000.0,"depreciationAndCashflowFromOperatingActivities":608272000.0,"cashFlowFromInvestingActivities":-246738000.0,"cashFlowFromFinancialActivities":-587636000.0,"changesInCashAndCashEquivalents":360993000.0,"列1":"asr","submitDate":"2017\/6\/29","stockCode":7634,"accountingYear":"第43期(自　平成28年４月１日　至　平成29年３月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":393.0,"averageTemporaryStaff":96.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1981000.0,"sharesOwendPercent":0.6,"outstandingShares":null,"numberOfSubsidiary":5.0,"bps":3562.02,"equityRatio":0.732,"cashAndCashEquivalents":7756503000.0,"assets":16076615000.0,"currentAssets":10502059000.0,"fixedAsset":5574556000.0,"tangibleFixedAssets":3948397000.0,"intangibleFixedAssets":13657000.0,"investmentAndOtherAssets":1612501000.0,"liabilities":4120231000.0,"currentLiabilities":3264594000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":855637000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":11956383000.0,"capitalStock":11537412000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":11100549000.0,"treasuryStock":-513025000.0,"valuationAndConversionAdjustments":227294000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":10434576000.0,"costOfSales":5222379000.0,"grossProfit":5212197000.0,"sgaExpenses":3962766000.0,"salaryAndBenefit":null,"depreciationAndSGA":146418000.0,"RDExpenses":null,"operatingIncome":1249430000.0,"nonOperatingIncome":27701000.0,"nonOperatingExpenses":7559000.0,"interestExpense":7559000.0,"ordinaryProfit":1269573000.0,"extraordinaryGain":1553000.0,"extraordinaryLoss":146000.0,"incomeBeforeTax":1270979000.0,"incomeTaxes":401986000.0,"netIncome":868993000.0,"netIncomeAttributableToOwnersOfTheParentCompany":862471000.0,"comprehensiveIncome":909375000.0,"eps":261.12,"dilutedEps":null,"dividendPerShare":null,"per":16.3,"roe":0.076,"cashFlowFromOperatingActivities":1428035000.0,"depreciationAndCashflowFromOperatingActivities":640124000.0,"cashFlowFromInvestingActivities":-385371000.0,"cashFlowFromFinancialActivities":-637360000.0,"changesInCashAndCashEquivalents":405304000.0,"列1":"asr","submitDate":"2018\/6\/28","stockCode":7634,"accountingYear":"第44期(自　平成29年４月１日　至　平成30年３月31日)","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":407.0,"averageTemporaryStaff":107.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1980000.0,"sharesOwendPercent":0.6,"outstandingShares":null,"numberOfSubsidiary":5.0,"bps":3769.15,"equityRatio":0.74,"cashAndCashEquivalents":8196383000.0,"assets":16814236000.0,"currentAssets":10840156000.0,"fixedAsset":5974080000.0,"tangibleFixedAssets":4268334000.0,"intangibleFixedAssets":16915000.0,"investmentAndOtherAssets":1688829000.0,"liabilities":4170499000.0,"currentLiabilities":3221813000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":948686000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12643737000.0,"capitalStock":12242653000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":11494215000.0,"treasuryStock":-201450000.0,"valuationAndConversionAdjustments":206017000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":10826673000.0,"costOfSales":5447901000.0,"grossProfit":5378772000.0,"sgaExpenses":4079674000.0,"salaryAndBenefit":null,"depreciationAndSGA":162002000.0,"RDExpenses":null,"operatingIncome":1299097000.0,"nonOperatingIncome":29026000.0,"nonOperatingExpenses":8282000.0,"interestExpense":8282000.0,"ordinaryProfit":1319840000.0,"extraordinaryGain":1036000.0,"extraordinaryLoss":59012000.0,"incomeBeforeTax":1261865000.0,"incomeTaxes":384777000.0,"netIncome":877087000.0,"netIncomeAttributableToOwnersOfTheParentCompany":870571000.0,"comprehensiveIncome":852683000.0,"eps":263.58,"dilutedEps":null,"dividendPerShare":null,"per":15.0,"roe":0.072,"cashFlowFromOperatingActivities":1870431000.0,"depreciationAndCashflowFromOperatingActivities":649905000.0,"cashFlowFromInvestingActivities":-754469000.0,"cashFlowFromFinancialActivities":-676082000.0,"changesInCashAndCashEquivalents":439880000.0,"列1":"asr","submitDate":"2019\/6\/27","stockCode":7634,"accountingYear":"第45期(自　2018年４月１日　至　2019年３月31日)","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.751,"cashAndCashEquivalents":null,"assets":16651425000.0,"currentAssets":10463665000.0,"fixedAsset":6187759000.0,"tangibleFixedAssets":4385069000.0,"intangibleFixedAssets":16351000.0,"investmentAndOtherAssets":1786337000.0,"liabilities":3950408000.0,"currentLiabilities":2996722000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":953685000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12701016000.0,"capitalStock":12201253000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":11610615000.0,"treasuryStock":-359250000.0,"valuationAndConversionAdjustments":303167000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2539198000.0,"costOfSales":1170117000.0,"grossProfit":1369080000.0,"sgaExpenses":1063717000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":305363000.0,"nonOperatingIncome":7153000.0,"nonOperatingExpenses":1986000.0,"interestExpense":1986000.0,"ordinaryProfit":310530000.0,"extraordinaryGain":18704000.0,"extraordinaryLoss":9971000.0,"incomeBeforeTax":319262000.0,"incomeTaxes":102288000.0,"netIncome":216974000.0,"netIncomeAttributableToOwnersOfTheParentCompany":215483000.0,"comprehensiveIncome":314163000.0,"eps":65.64,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/14","stockCode":7634,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1916000.0,"sharesOwendPercent":0.587,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.761,"cashAndCashEquivalents":7322453000.0,"assets":16705621000.0,"currentAssets":9388883000.0,"fixedAsset":7316737000.0,"tangibleFixedAssets":5554185000.0,"intangibleFixedAssets":15787000.0,"investmentAndOtherAssets":1746765000.0,"liabilities":3799631000.0,"currentLiabilities":2856699000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":942932000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12905989000.0,"capitalStock":12423883000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":11833245000.0,"treasuryStock":-359250000.0,"valuationAndConversionAdjustments":283695000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":5313196000.0,"costOfSales":2530603000.0,"grossProfit":2782593000.0,"sgaExpenses":2120269000.0,"salaryAndBenefit":863693000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":662324000.0,"nonOperatingIncome":21380000.0,"nonOperatingExpenses":7134000.0,"interestExpense":7134000.0,"ordinaryProfit":676570000.0,"extraordinaryGain":18778000.0,"extraordinaryLoss":44853000.0,"incomeBeforeTax":650494000.0,"incomeTaxes":208337000.0,"netIncome":442157000.0,"netIncomeAttributableToOwnersOfTheParentCompany":438113000.0,"comprehensiveIncome":519135000.0,"eps":133.86,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":818499000.0,"depreciationAndCashflowFromOperatingActivities":331412000.0,"cashFlowFromInvestingActivities":-1166688000.0,"cashFlowFromFinancialActivities":-525741000.0,"changesInCashAndCashEquivalents":-873930000.0,"列1":"q2r","submitDate":"2019\/11\/12","stockCode":7634,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.772,"cashAndCashEquivalents":null,"assets":16676244000.0,"currentAssets":9287219000.0,"fixedAsset":7389025000.0,"tangibleFixedAssets":5563826000.0,"intangibleFixedAssets":17451000.0,"investmentAndOtherAssets":1807747000.0,"liabilities":3601771000.0,"currentLiabilities":2693427000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":908343000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13074473000.0,"capitalStock":12549522000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":11958884000.0,"treasuryStock":-359250000.0,"valuationAndConversionAdjustments":325664000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":7859674000.0,"costOfSales":3731951000.0,"grossProfit":4127723000.0,"sgaExpenses":3176566000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":951157000.0,"nonOperatingIncome":38712000.0,"nonOperatingExpenses":10330000.0,"interestExpense":6540000.0,"ordinaryProfit":979539000.0,"extraordinaryGain":18778000.0,"extraordinaryLoss":42909000.0,"incomeBeforeTax":955408000.0,"incomeTaxes":306231000.0,"netIncome":649177000.0,"netIncomeAttributableToOwnersOfTheParentCompany":645321000.0,"comprehensiveIncome":769188000.0,"eps":197.38,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":7634,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":418.0,"averageTemporaryStaff":108.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1852000.0,"sharesOwendPercent":0.568,"outstandingShares":null,"numberOfSubsidiary":5.0,"bps":3933.55,"equityRatio":0.737,"cashAndCashEquivalents":7397834000.0,"assets":17408817000.0,"currentAssets":9938063000.0,"fixedAsset":7470754000.0,"tangibleFixedAssets":5635816000.0,"intangibleFixedAssets":16781000.0,"investmentAndOtherAssets":1818155000.0,"liabilities":4375677000.0,"currentLiabilities":3154090000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1221586000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13033140000.0,"capitalStock":12638831000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":12048418000.0,"treasuryStock":-359474000.0,"valuationAndConversionAdjustments":195261000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":10878661000.0,"costOfSales":5344065000.0,"grossProfit":5534596000.0,"sgaExpenses":4496974000.0,"salaryAndBenefit":null,"depreciationAndSGA":150293000.0,"RDExpenses":20064000.0,"operatingIncome":1037622000.0,"nonOperatingIncome":51689000.0,"nonOperatingExpenses":14064000.0,"interestExpense":8824000.0,"ordinaryProfit":1075247000.0,"extraordinaryGain":19078000.0,"extraordinaryLoss":42925000.0,"incomeBeforeTax":1051399000.0,"incomeTaxes":311047000.0,"netIncome":740352000.0,"netIncomeAttributableToOwnersOfTheParentCompany":734855000.0,"comprehensiveIncome":728080000.0,"eps":224.88,"dilutedEps":null,"dividendPerShare":null,"per":24.2,"roe":0.058,"cashFlowFromOperatingActivities":1462977000.0,"depreciationAndCashflowFromOperatingActivities":682995000.0,"cashFlowFromInvestingActivities":-1379277000.0,"cashFlowFromFinancialActivities":-882250000.0,"changesInCashAndCashEquivalents":-798549000.0,"列1":"asr","submitDate":"2020\/6\/30","stockCode":7634,"accountingYear":"第46期(自　2019年４月１日　至　2020年３月31日)","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.739,"cashAndCashEquivalents":null,"assets":17584195000.0,"currentAssets":9910502000.0,"fixedAsset":7673693000.0,"tangibleFixedAssets":5748017000.0,"intangibleFixedAssets":16111000.0,"investmentAndOtherAssets":1909565000.0,"liabilities":4397969000.0,"currentLiabilities":3116937000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1281032000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13186226000.0,"capitalStock":12727263000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":12136850000.0,"treasuryStock":-359474000.0,"valuationAndConversionAdjustments":259740000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2592180000.0,"costOfSales":1233799000.0,"grossProfit":1358380000.0,"sgaExpenses":1111599000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":246780000.0,"nonOperatingIncome":8684000.0,"nonOperatingExpenses":4078000.0,"interestExpense":1389000.0,"ordinaryProfit":251387000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":251387000.0,"incomeTaxes":82044000.0,"netIncome":169343000.0,"netIncomeAttributableToOwnersOfTheParentCompany":170000000.0,"comprehensiveIncome":234654000.0,"eps":52.1,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/13","stockCode":7634,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1786000.0,"sharesOwendPercent":0.548,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.741,"cashAndCashEquivalents":7951219000.0,"assets":17888374000.0,"currentAssets":10115885000.0,"fixedAsset":7772488000.0,"tangibleFixedAssets":5784747000.0,"intangibleFixedAssets":15441000.0,"investmentAndOtherAssets":1972300000.0,"liabilities":4433506000.0,"currentLiabilities":3081008000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1352497000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13454868000.0,"capitalStock":12952137000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":12361723000.0,"treasuryStock":-359474000.0,"valuationAndConversionAdjustments":301216000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":5397761000.0,"costOfSales":2629028000.0,"grossProfit":2768733000.0,"sgaExpenses":2173276000.0,"salaryAndBenefit":929245000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":595456000.0,"nonOperatingIncome":24832000.0,"nonOperatingExpenses":25864000.0,"interestExpense":2609000.0,"ordinaryProfit":594425000.0,"extraordinaryGain":null,"extraordinaryLoss":10090000.0,"incomeBeforeTax":584335000.0,"incomeTaxes":189168000.0,"netIncome":395167000.0,"netIncomeAttributableToOwnersOfTheParentCompany":394873000.0,"comprehensiveIncome":503296000.0,"eps":121.03,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1104462000.0,"depreciationAndCashflowFromOperatingActivities":366826000.0,"cashFlowFromInvestingActivities":-150741000.0,"cashFlowFromFinancialActivities":-400335000.0,"changesInCashAndCashEquivalents":553384000.0,"列1":"q2r","submitDate":"2020\/11\/12","stockCode":7634,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.727,"cashAndCashEquivalents":null,"assets":17707719000.0,"currentAssets":10031970000.0,"fixedAsset":7675749000.0,"tangibleFixedAssets":5695717000.0,"intangibleFixedAssets":9543000.0,"investmentAndOtherAssets":1970488000.0,"liabilities":4624368000.0,"currentLiabilities":3260345000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1364023000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13083350000.0,"capitalStock":12516909000.0,"capital":436180000.0,"capitalSurplus":513708000.0,"accumulatedEarnings":12554867000.0,"treasuryStock":-987846000.0,"valuationAndConversionAdjustments":361358000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":8259550000.0,"costOfSales":4033904000.0,"grossProfit":4225645000.0,"sgaExpenses":3235179000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":990466000.0,"nonOperatingIncome":37348000.0,"nonOperatingExpenses":28865000.0,"interestExpense":3796000.0,"ordinaryProfit":998949000.0,"extraordinaryGain":27230000.0,"extraordinaryLoss":35134000.0,"incomeBeforeTax":991046000.0,"incomeTaxes":317733000.0,"netIncome":673312000.0,"netIncomeAttributableToOwnersOfTheParentCompany":669585000.0,"comprehensiveIncome":841718000.0,"eps":208.71,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":7634,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":431.0,"averageTemporaryStaff":107.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1664000.0,"sharesOwendPercent":0.539,"outstandingShares":null,"numberOfSubsidiary":5.0,"bps":4289.53,"equityRatio":0.698,"cashAndCashEquivalents":8372714000.0,"assets":18988261000.0,"currentAssets":11121908000.0,"fixedAsset":7866352000.0,"tangibleFixedAssets":5811703000.0,"intangibleFixedAssets":8743000.0,"investmentAndOtherAssets":2045905000.0,"liabilities":5526940000.0,"currentLiabilities":4127859000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1399081000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13461320000.0,"capitalStock":12911099000.0,"capital":436180000.0,"capitalSurplus":528801000.0,"accumulatedEarnings":12879260000.0,"treasuryStock":-933142000.0,"valuationAndConversionAdjustments":342124000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":11809283000.0,"costOfSales":6043312000.0,"grossProfit":5765971000.0,"sgaExpenses":4324977000.0,"salaryAndBenefit":null,"depreciationAndSGA":140669000.0,"RDExpenses":23566000.0,"operatingIncome":1440993000.0,"nonOperatingIncome":53296000.0,"nonOperatingExpenses":31302000.0,"interestExpense":5616000.0,"ordinaryProfit":1462987000.0,"extraordinaryGain":28979000.0,"extraordinaryLoss":35134000.0,"incomeBeforeTax":1456832000.0,"incomeTaxes":455976000.0,"netIncome":1000856000.0,"netIncomeAttributableToOwnersOfTheParentCompany":993978000.0,"comprehensiveIncome":1149890000.0,"eps":313.14,"dilutedEps":null,"dividendPerShare":null,"per":12.0,"roe":0.076,"cashFlowFromOperatingActivities":2479641000.0,"depreciationAndCashflowFromOperatingActivities":765527000.0,"cashFlowFromInvestingActivities":-64142000.0,"cashFlowFromFinancialActivities":-1440618000.0,"changesInCashAndCashEquivalents":974880000.0,"列1":"asr","submitDate":"2021\/6\/24","stockCode":7634,"accountingYear":"第47期(自　2020年４月１日　至　2021年３月31日)","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.71,"cashAndCashEquivalents":null,"assets":18771345000.0,"currentAssets":10761411000.0,"fixedAsset":8009933000.0,"tangibleFixedAssets":5915279000.0,"intangibleFixedAssets":26173000.0,"investmentAndOtherAssets":2068480000.0,"liabilities":5226235000.0,"currentLiabilities":3766054000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1460181000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13545109000.0,"capitalStock":12975775000.0,"capital":436180000.0,"capitalSurplus":528801000.0,"accumulatedEarnings":12943936000.0,"treasuryStock":-933142000.0,"valuationAndConversionAdjustments":358750000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2906095000.0,"costOfSales":1512139000.0,"grossProfit":1393955000.0,"sgaExpenses":1184057000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":209898000.0,"nonOperatingIncome":9242000.0,"nonOperatingExpenses":3714000.0,"interestExpense":2078000.0,"ordinaryProfit":215426000.0,"extraordinaryGain":null,"extraordinaryLoss":0.0,"incomeBeforeTax":215426000.0,"incomeTaxes":70852000.0,"netIncome":144573000.0,"netIncomeAttributableToOwnersOfTheParentCompany":141917000.0,"comprehensiveIncome":161030000.0,"eps":45.93,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/13","stockCode":7634,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1556000.0,"sharesOwendPercent":0.504,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.711,"cashAndCashEquivalents":8579668000.0,"assets":19285209000.0,"currentAssets":11049372000.0,"fixedAsset":8235837000.0,"tangibleFixedAssets":5995305000.0,"intangibleFixedAssets":55895000.0,"investmentAndOtherAssets":2184635000.0,"liabilities":5368676000.0,"currentLiabilities":3851741000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1516934000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13916533000.0,"capitalStock":13255246000.0,"capital":436180000.0,"capitalSurplus":528801000.0,"accumulatedEarnings":13223407000.0,"treasuryStock":-933142000.0,"valuationAndConversionAdjustments":448498000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":5949418000.0,"costOfSales":2999447000.0,"grossProfit":2949970000.0,"sgaExpenses":2337220000.0,"salaryAndBenefit":975212000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":612750000.0,"nonOperatingIncome":21423000.0,"nonOperatingExpenses":8799000.0,"interestExpense":4155000.0,"ordinaryProfit":625374000.0,"extraordinaryGain":1536000.0,"extraordinaryLoss":0.0,"incomeBeforeTax":626910000.0,"incomeTaxes":201409000.0,"netIncome":425500000.0,"netIncomeAttributableToOwnersOfTheParentCompany":421388000.0,"comprehensiveIncome":532454000.0,"eps":136.39,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":901814000.0,"depreciationAndCashflowFromOperatingActivities":429745000.0,"cashFlowFromInvestingActivities":-239837000.0,"cashFlowFromFinancialActivities":-455023000.0,"changesInCashAndCashEquivalents":206953000.0,"列1":"q2r","submitDate":"2021\/11\/15","stockCode":7634,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0},{"edinetCode":"E03330","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.714,"cashAndCashEquivalents":null,"assets":19364808000.0,"currentAssets":10894563000.0,"fixedAsset":8470244000.0,"tangibleFixedAssets":6265993000.0,"intangibleFixedAssets":85980000.0,"investmentAndOtherAssets":2118270000.0,"liabilities":5331765000.0,"currentLiabilities":3788552000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1543212000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":14033042000.0,"capitalStock":13450802000.0,"capital":436180000.0,"capitalSurplus":528801000.0,"accumulatedEarnings":13419121000.0,"treasuryStock":-933300000.0,"valuationAndConversionAdjustments":369120000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":9064849000.0,"costOfSales":4611554000.0,"grossProfit":4453295000.0,"sgaExpenses":3445521000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1007773000.0,"nonOperatingIncome":31888000.0,"nonOperatingExpenses":9125000.0,"interestExpense":6272000.0,"ordinaryProfit":1030536000.0,"extraordinaryGain":1916000.0,"extraordinaryLoss":72000.0,"incomeBeforeTax":1032379000.0,"incomeTaxes":330800000.0,"netIncome":701579000.0,"netIncomeAttributableToOwnersOfTheParentCompany":694344000.0,"comprehensiveIncome":726363000.0,"eps":224.73,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/7","stockCode":7634,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E03330","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":436,"settlementDate":"2022\/3\/31","submitterName":"株式会社星医療酸器","submitterNameEnglish":"HOSHIIRYO-SANKI CO., LTD.","submitterNameKana":"カブシキガイシャホシイリョウサンキ","location":"足立区入谷七丁目１１番１８号","industory":"卸売業","corporateNumber":2010000000000.0}]